Open AccessPB1985: CHEMO OR CHEMO‐FREE REGIMENS IN HEAVILY PRETREATED MULTIPLE MYELOMA? ROLE OF BENDAMUSTINE‐BORTEZOMIB‐DEXAMETHASONE (BVD) IN NOVEL AGENTS’ ERA
Author(s) -
Cerchione C.,
Nappi D.,
Pareto A. E.,
Ronconi S.,
Cangini D.,
Ceccolini M.,
Musuraca G.,
Catalano L.,
Martinelli G.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000850776.29544.87
Subject(s) - bendamustine , medicine , bortezomib , multiple myeloma , salvage therapy , refractory (planetary science) , pegfilgrastim , dexamethasone , surgery , oncology , neutropenia , gastroenterology , chemotherapy , rituximab , febrile neutropenia , lymphoma , physics , astrobiology